Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2025-08-21 00:00:00 ET · period of report 2025-08-21 · accession 0001999371-25-011836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-21 | 2025-08-21 | TNXP | Taylor Carolyn E. | Dir | P - Purchase | $36.03 | +418 | 418 | New | +$15.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2025-08-21 | P | A | 418 | $36.03 | 418 | D | — | — | (F1) Represents the weighted average purchase price. Actual purchase prices ranged from $35.98 to $36.05. |